Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Short Interest Up 37.4% in November

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 20,200 shares, a growth of 37.4% from the November 15th total of 14,700 shares. Based on an average daily volume of 19,000 shares, the short-interest ratio is currently 1.1 days. Approximately 0.6% of the shares of the stock are sold short.

Hedge Funds Weigh In On Cryo-Cell International

A hedge fund recently raised its stake in Cryo-Cell International stock. Geode Capital Management LLC increased its holdings in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) by 68.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 39,860 shares of the company’s stock after purchasing an additional 16,203 shares during the period. Geode Capital Management LLC owned 0.49% of Cryo-Cell International worth $254,000 as of its most recent SEC filing. 10.44% of the stock is currently owned by institutional investors and hedge funds.

Cryo-Cell International Trading Up 0.4 %

CCEL traded up $0.03 on Friday, hitting $7.93. 3,636 shares of the company were exchanged, compared to its average volume of 11,126. Cryo-Cell International has a fifty-two week low of $4.47 and a fifty-two week high of $9.50. The firm has a market capitalization of $63.92 million, a P/E ratio of -7.42 and a beta of 0.49.

Cryo-Cell International (NYSEAMERICAN:CCEL) last issued its quarterly earnings data on Tuesday, October 15th. The company reported $0.13 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.11. The firm had revenue of $8.07 million for the quarter. Cryo-Cell International had a negative net margin of 28.03% and a negative return on equity of 42.06%.

Cryo-Cell International Announces Dividend

The business also recently announced a — dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were paid a $0.25 dividend. The ex-dividend date of this dividend was Friday, November 15th. Cryo-Cell International’s payout ratio is currently -94.34%.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.